Literature DB >> 19081250

Synthesis of H-bonding probes of alpha7 nAChR agonist selectivity.

Jingyi Wang1, Roger L Papke, Nicole A Horenstein.   

Abstract

The alpha7 subtype of the nicotinic acetylcholine receptor (nAChR) is the target of studies aimed at identifying features that will lead to the development of selective therapeutics. Five arylidine anabaseines, three with pyridine rings and two with the pyrrole rings, were synthesized in 35-65% yield via aldol condensation. The compounds are homologs of benzylidine anabaseine and were chosen for synthesis because they provide either a hydrogen bond acceptor (pyridines) or hydrogen bond donor (pyrroles) that may interact with the receptor within the benzylidine selectivity motif. Initial analysis of the new compounds at 100 microM concentration reveal that the two pyrrole anabaseines are good partial agonists of the alpha7 nAChR, having 40% of the efficacy of ACh, efficacy comparable to 4OH-GTS-21, and dramatically enhanced efficacy relative to the 2- and 4-pyridinyl compounds. The pyrrole compounds were confirmed to be alpha7 selective, displaying preference for this receptor over muscle and heteromeric neuronal receptor subtypes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19081250      PMCID: PMC2639621          DOI: 10.1016/j.bmcl.2008.11.044

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  16 in total

Review 1.  Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.

Authors:  John A Dani; Daniel Bertrand
Journal:  Annu Rev Pharmacol Toxicol       Date:  2007       Impact factor: 13.820

2.  Quinuclidines as selective agonists for alpha-7 nicotinic acetylcholine receptors.

Authors:  Fedra M Leonik; Roger L Papke; Nicole A Horenstein
Journal:  Bioorg Med Chem Lett       Date:  2007-01-12       Impact factor: 2.823

Review 3.  Familial transmission of risk factors in the first-degree relatives of schizophrenic people.

Authors:  M C Waldo; L E Adler; S Leonard; A Olincy; R G Ross; J G Harris; R Freedman
Journal:  Biol Psychiatry       Date:  2000-02-01       Impact factor: 13.382

4.  Pharmacological characterization of nicotine-induced seizures in mice.

Authors:  M I Damaj; W Glassco; M Dukat; B R Martin
Journal:  J Pharmacol Exp Ther       Date:  1999-12       Impact factor: 4.030

5.  Altered baroreflex responses in alpha7 deficient mice.

Authors:  D Franceschini; A Orr-Urtreger; W Yu; L Y Mackey; R A Bond; D Armstrong; J W Patrick; A L Beaudet; M De Biasi
Journal:  Behav Brain Res       Date:  2000-08       Impact factor: 3.332

6.  Characterization of bovine and human neuronal nicotinic acetylcholine receptors using monoclonal antibodies.

Authors:  P J Whiting; J M Lindstrom
Journal:  J Neurosci       Date:  1988-09       Impact factor: 6.167

7.  3-[2,4-Dimethoxybenzylidene]anabaseine (DMXB) selectively activates rat alpha7 receptors and improves memory-related behaviors in a mecamylamine-sensitive manner.

Authors:  E M Meyer; E T Tay; R L Papke; C Meyers; G L Huang; C M de Fiebre
Journal:  Brain Res       Date:  1997-09-12       Impact factor: 3.252

8.  A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment.

Authors:  C M Flores; S W Rogers; L A Pabreza; B B Wolfe; K J Kellar
Journal:  Mol Pharmacol       Date:  1992-01       Impact factor: 4.436

Review 9.  The alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammation.

Authors:  W J de Jonge; L Ulloa
Journal:  Br J Pharmacol       Date:  2007-05-14       Impact factor: 8.739

10.  Alpha7 nicotinic acetylcholine receptor gene and reduced risk of Alzheimer's disease.

Authors:  R Carson; D Craig; B McGuinness; J A Johnston; F A O'Neill; A P Passmore; C W Ritchie
Journal:  J Med Genet       Date:  2007-12-05       Impact factor: 6.318

View more
  2 in total

1.  Potential state-selective hydrogen bond formation can modulate activation and desensitization of the α7 nicotinic acetylcholine receptor.

Authors:  Jingyi Wang; Roger L Papke; Clare Stokes; Nicole A Horenstein
Journal:  J Biol Chem       Date:  2012-05-03       Impact factor: 5.157

2.  Synthesis and evaluation of a conditionally-silent agonist for the α7 nicotinic acetylcholine receptor.

Authors:  Kinga Chojnacka; Roger L Papke; Nicole A Horenstein
Journal:  Bioorg Med Chem Lett       Date:  2013-05-23       Impact factor: 2.823

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.